Resistance to Adora2b/PD-1 dual blockade is partially mediated by IL-8 secreted by myeloid-derived suppressor cells (MDSCs): In non-responding gastric cancer patients, IL-8 levels were 3.2 times higher than in responders (p<0.001). This evidence concerns the gene CXCL8 and gastric cancer.